Condition
Malignant Pleural Mesothelioma
Estimated Enrollment: 17
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: I207
Study First Received: December 1, 2011
Last Updated: September 16, 2016
Estimated Primary Completion Date: April 2014
Primary Outcome Measures:
Response Rate|Amount and severity of adverse events|Duration of Response|Blood and tissue marker evaluation
Sponsors and Collaborators:
NCIC Clinical Trials Group|Canadian Cancer Trials Group
Website Link: https://ClinicalTrials.gov/show/NCT01486368
